View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Design Therapeutics to Participate in Upcoming Investor Conferences

Design Therapeutics to Participate in Upcoming Investor Conferences CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will present at the following upcoming investor conferences: Oppenheimer 36th Annual Healthcare Life Sciences Conference on Wednesday, February 25, 2026, at 1:20 p.m. ET (virtual)Leerink Partners Global Healthcare Conference on Tuesday, March 10, 2026, at 2:20 p.m. ET in Miami, FL Live webcasts...

Wedbush Research
  • Wedbush Research
 PRESS RELEASE

Telos Corporation Renews $5.4M Cyber GRC Engagement with Leading Globa...

Telos Corporation Renews $5.4M Cyber GRC Engagement with Leading Global Technology Company Contract expansion reflects nearly four-year relationship supporting large-scale cloud security and compliance operations ASHBURN, Va., Jan. 08, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced the renewal of its ongoing partnership with a Fortune 100 global technology company to deliver cyber governance, risk, and compliance (GRC) and security operations support for ...

 PRESS RELEASE

Telos Corporation Selected for Missile Defense Agency SHIELD IDIQ Cont...

Telos Corporation Selected for Missile Defense Agency SHIELD IDIQ Contract ASHBURN, Va., Dec. 19, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced it was awarded a contract for the Missile Defense Agency Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) indefinite-delivery/indefinite-quantity (IDIQ) contract with a ceiling of $151 billion. This contract encompasses a broad range of work areas that allows for the rapid delivery of innovative cap...

Zimmer Biomet Holdings, Inc.: Update to credit analysis

Our credit view of this issuer reflects its healthy EBITDA margin and strong free cash flow generation, constrained by its pricing pressure from competition.

Moody's Ratings affirms Zimmer Biomet's Baa2 senior unsecured rating; ...

Moody's Ratings (Moody's) affirmed the senior unsecured ratings of Zimmer Biomet Holdings, Inc. ("Zimmer Biomet") at Baa2. The outlook is stable. The ratings affirmation reflects solid operating performance due to strong demand and operational improvements that have contributed to solid organic gr...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: December 6, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: December 3, 2025

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Design Therapeutics to Participate in Upcoming Investor Conferences

Design Therapeutics to Participate in Upcoming Investor Conferences CARLSBAD, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in fireside chats at the following upcoming investor conferences: Piper Sandler 37th Annual Healthcare Conference on Wednesday, December 3, 2025, at 3:30 p.m. ET in New York, NYEvercore 8th Annual Healthcare Conference on Thursday, December 4, 2025, at 10:00 a.m. ET in Coral Gab...

Anish Jog ... (+4)
  • Anish Jog
  • Daniel Ives
  • Sam Brandeis
  • Steven Wahrhaftig

Strong Results and Momentum Heading into Year End; Raise PT to $10

A Closer Look at FY3Q25 (September) ResultsRevenueTotal revenue for the quarter was $51.4 million (up 116% y/y) and came in above both the Street’s estimate of $45.7 million and the company’s guidance range of $44.0 million to $47.0 million. Security Solutions segment came in at $46.5 million (up 1

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

 PRESS RELEASE

Telos Corporation Announces Third Quarter 2025 Earnings

Telos Corporation Announces Third Quarter 2025 Earnings ASHBURN, Va., Nov. 10, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, has posted its 2025 third quarter financial results on its investor relations website at . Telos will host a live webcast to discuss its third quarter 2025 financial results today, November 10, 2025, at 9:30 a.m. ET. To access the webcast, visit . Related presentation materials will be made available on the Investors section of the Company’s websi...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch